The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a major cancer need

Clinical Cancer Research

Volumn 12, Issue 11 II, 2006, Pages

  Cohen, Harvey Jay ^a   Muss, Hyman B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; RITUXIMAB;

AGING; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; COMORBIDITY; DRUG EFFICACY; ELDERLY CARE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HORMONAL THERAPY; HUMAN; LEUKEMIA; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LEUKEMIA; NEOPLASMS; QUALITY OF LIFE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33745208641     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-9007     Document Type: Review

References (18)

1. Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol 2004;31:128-36.
2. Yancik R. Population aging and cancer: a cross-national concern. Cancer J 2005;11:437-41.
3. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-17.
4. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-7.
5. Kimmick GG, Peterson BL, Kornblith AB, et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol 2005;23:2201-7.
6. Kemeny MM, Peterson BL, Kornblith AB, et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21 2268-75.
7. Muss HB, Cohen HJ, Lichtman SM. Clinical research in the older cancer patient. Hematol Oncol Clin North Am 2000;14:283-91.
8. Kornblith AB, Kemeny M, Peterson BL, et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 2002;95:989-96.
9. Kuo HK, Scandrett KG, Dave J, Mitchell SL. The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis. Arch Gerontol Geriatr 2004;39:245-54.
10. Rao AV, Seo PH, Cohen HJ. Geriatric assessment and comorbidity. Semin Oncol 2004;31:149-59.
11. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005;104:1998-2005.
12. Lichtman SM, Hollis D, Miller AA, et al. Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology. Cancer and Leukemia Group B (CALGB 9762). J Clin Oncol 2006;24:1846-51.
13. Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:1073-81.
14. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-7.
15. Habermann TM, Weller E, Morrison AV, et al. Rituximab-CHOP versus CHOP with or without maintenance Rituximab in patients 60 years or age or older with diffuse large B-cell lymphoma (DLBCL): an update. Blood 2004;104:40a.
16. Halabi S, Small EJ, Kantoff PW, et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol 2003;21:1232-7.
17. Halabi S, Vogelzang NJ, Ou S-S, Small EJ. Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of eight Cancer and Leukemia Group B (CALGB) studies. The Journal of Urology. In press 2006 July.
18. Kornblith AB, Dowell JM, Herndon JE II, et al. Telephone monitoring: early identification of psychological, physical and social distress in older advanced stage cancer patients. Psychooncology 2006;15:S21-2.